Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for fluphenazine decanoate filed by Sagent Pharmaceuticals, resulting in updated labeling for this long-acting antipsych…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

SUPPL AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)